17hon MSNOpinion
Contributor: Vaccine confusion sets up U.S. for a resurgence of hepatitis B in babies
The lesson from the past is simple. When we stop using vaccines that work, the diseases they prevent come back.
11monon MSN
What to know about the hep B vaccine
There's a vaccine for hepatitis B that, according to the CDC, can help to prevent millions of deaths worldwide.
—In a global study of 614 adults with chronic hepatitis B (CHB), treatment compliance was affected by obstacles such as physical functioning and healthcare service accessibility, making clear the need ...
More than 75% of chronic hepatitis B diagnoses in the United States occur late — within 2 years before or after the onset of a liver complication — highlighting the need for improved screening to ...
Future Virology. 2012;7(10):955-972. Four studies in children investigated the combination of lamivudine with interferon-α in treatment-naive children with elevated aminotransferases. [32–35] The ...
Hepatitis B is a serious liver disease caused by the hepatitis B virus (HBV), which is a small DNA virus from the Hepadnaviridae family. If someone has this infection for a long time, it can lead to ...
In adults with chronic hepatitis B infection receiving viral suppression therapy, coupling an investigational small interfering RNA therapy with an immunomodulator led to substantial declines in blood ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is pictured in the main lobby of GSK offices in London, Britain, February 20, 2025. REUTERS/Chris J. Ratcliffe ...
Hepatitis B viral load is the amount of hepatitis B virus (HBV) found in a person’s bloodstream. Hepatitis B is a viral infection that can pass from person to person through bodily fluids. It ...
People may be at more risk of both AIDS and hepatitis B due to similar risk factors. Having HIV and hepatitis B may lead to serious complications. However, both are treatable and preventable. Stage 3 ...
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results